http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101158908-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2010-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101158908-B1 |
| titleOfInvention | CEP68 Gene Variants Associated with Risk of Aspirin Tolerant Asthma |
| abstract | The present invention relates to the analysis of the association between the risk of aspirin intolerant asthma and the CEP68 gene polymorphism. The present invention provides a CEP68 (Centrosomal protein 68 kDa) gene with a single base mutation for the diagnosis or prediction of aspirin intolerant asthma; And CEP68 Haplotype. The present invention also provides a method for providing information for the diagnosis or prediction of aspirin intolerant asthma using the CEP68 gene having a single base mutation. The present invention suggests that it is possible to diagnose and predict asthma associated with aspirin intolerance by analyzing the CEP68 gene polymorphism, which may be usefully used in new drug development, disease diagnosis, and treatment. |
| priorityDate | 2010-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.